Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 9:01 PM ET

Date/Time Source News Release
12/18/2023 09:15 AM EST GlobeNewswire Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
11/13/2023 02:15 PM EST GlobeNewswire Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
11/03/2023 09:15 AM EDT GlobeNewswire Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board
10/04/2023 09:15 AM EDT GlobeNewswire Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
06/27/2023 09:20 AM EDT GlobeNewswire Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
05/23/2023 08:30 AM EDT PR Newswire Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
04/03/2023 08:30 AM EDT PR Newswire Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University
02/23/2023 08:30 AM EST PR Newswire Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone
01/17/2023 08:30 AM EST PR Newswire Theralink's Exclusive Licensed RPPA Technology for Commercial Laboratory Testing to Assist the White House Cancer Moonshot Initiative
01/09/2023 08:00 AM EST PR Newswire Theralink® Technologies Appoints Michael Vallone as Senior Director of Commercialization
Page

Additional News

As of June 12, 2025 • 9:01 PM ET

Date/Time Source News Release
03/14/2024 02:54 PM EDT SeekingAlpha Biotech bankruptcies hit a record despite sector's recovery
07/26/2023 11:01 AM EDT SeekingAlpha IMAC Holdings announces $4.3M offering of convertible preferred stock and warrants priced at the market
06/27/2023 09:47 AM EDT SeekingAlpha Theralink names Faith Zaslavsky as CEO
05/23/2023 09:07 AM EDT SeekingAlpha IMAC Holdings up 25% on acquisition of Theralink
07/25/2022 09:37 AM EDT SeekingAlpha Theralink acquires two new milestone patents for breast cancer treatment
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.